How the SARS vaccine effort can learn from HIV - Speeding towards the future, learning from the past

Vaccine

Volumn 21, Issue 27-30, 2003, Pages 4095-4104

  De Groot, Anne S ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Coronavirus; HIV; SARS; Vaccine

Indexed keywords

DNA VACCINE; EPITOPE; INACTIVATED VACCINE; LIVE VACCINE; RECOMBINANT VACCINE; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

CLINICAL FEATURE; CORONAVIRUS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; EPIDEMIC; GENE AMPLIFICATION; GENE SEQUENCE; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOPATHOGENESIS; INFECTION PREVENTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA VIRUS; SARS CORONAVIRUS; SEASONAL VARIATION; SEVERE ACUTE RESPIRATORY SYNDROME; UPPER RESPIRATORY TRACT INFECTION; VIRUS GENOME; VIRUS NEUTRALIZATION; VIRUS PNEUMONIA; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 0348078300     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00489-4     Document Type: Note

References (48)

1. Marra MA, Jones SJ, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science 2003;300(5624):624-29.
2. Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300(5624):1394-9.
3. Kaisernet.org, VaxGen AIDS Vaccine 'Largely Ineffective' at Reducing HIV Infection Rate; African Americans, Asians Show Stronger Protective Effect Kaiser Daily HIV/AIDS Report, Monday, 24 February 2003. http://www.kaisernetwork.org/daily_reports/print_report.cfm?DR_ID= 16196&dr_cat=1.
4. De Groot AS, Sbai H, et al. Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach. Vaccine [in proofs].
5. Ruan Y., Wei C.L., Ee A.L.et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet. 361:2003;1779-1785.
6. Prentice E., Dension M.R. The cell biology of coronavirus infection. Adv. Exp. Med. Biol. 494:2001;609-614.
7. Peiris J.S.M., Lai S.T., Poon L.L.M.et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 361(9371):2003;1779-1785.
8. Pewe L., Heard S.B., Bergmann C., Dailey M.O., Perlman S. Selection of CTL escape mutants in mice infected with a neurotropic coronavirus: quantitative estimate of TCR diversity in the infected central nervous system. J. Immunol. 163(11):1999;6106-6113.
9. Bergmann C.C., Dimacali E., Stohl S., Marten N., Lai M.M., Stohlman S.A. Viral evolution and CTL epitope stability during JHMV infection in the central nervous system. Adv. Exp. Med. Biol. 440:1998;751-757.
10. Hasoksuz M., Sreevatsan S., Cho K.O., Hoet A.E., Saif L.J. Molecular analysis of the S1 subunit of the spike glycoprotein of respiratory and enteric bovine coronavirus isolates. Virus Res. 84(1-2):2002;101-109.
11. Drosten C., Gunther S., Preiser W.et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348(20):2003;1967-1976.
12. Ksiazek T.G., Erdman D., Goldsmith C.S.et al. A novel coronavirus associated with severe acute respiratory symptom. N. Engl. J. Med. 348(20):2003;1953-1966.
13. Chua M.M., Phillips J.J., Seo S.H., Lavi E., Weiss S.R. Mutation of the immunodominant CD8+ epitope in the MHV-4 spike protein. Adv. Exp. Med. Biol. 494:2001;121-125.
14. Booth C.M., Matukas L.M., Tomlinson G.A.et al. Clinical features and short-term outcomes of 144 patients With SARS in the Greater Toronto Area. JAMA. 289(21):2003;2801-2809.
15. Lee N., Hui D., Wu A.et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348(20):2003;1986-1994.
16. Poutanen S.M., Low D.E., Henry B.et al. Identification of severe acute respiratory syndrome in Canada. N. Engl. J. Med. 348(20):2003;1995-2005.
17. Phillips J.J., Chua M.M., Rall G.F., Weiss S.R. Murine coronavirus spike glycoprotein mediates degree of viral spread, inflammation, and virus-induced immunopathology in the central nervous system. Virology. 301(1):2002;109-120.
18. Update 65 - 24 May 2003 Situation in Toronto Communicable Disease Surveillance & Response (CSR) from the WHO SARS website. http://www.who.int/csr/don/2003_05_24/en/.
19. Castro R.F., Perlman S. CD8+ T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J. Virol. 69(12):1995;8127-8131.
20. Wu G.F., Dandekar A.A., Pewe L., Perlman S. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J. Immunol. 165(4):2000;2278-2286.
21. De Herdt P, Ducatelle AR, Uyttebroek AE, Sneep A, Torbeyns R. Infectious bronchitis serology in broilers and broiler breeders: correlations between antibody titers and performance in vaccinated flocks. Avian Dis 45(3):612-9.
22. O'Connor A., Martin S.W., Nagy E., Menzies P., Harland R. The relationship between the occurrence of undifferentiated bovine respiratory disease and titer changes to bovine coronavirus and bovine viral diarrhea virus in 3 Ontario feedlots. Can. J. Vet. Res. 65(3):2001;137-142.
23. Liu M.F., Ning Q., Pope M.et al. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection. Adv. Exp. Med. Biol. 440:1998;415-423.
24. Xue S., Perlman S. Antigen specificity of CD4 T cell response in the central nervous system of mice infected with mouse hepatitis virus. Virology. 238(1):1997;68-78.
25. de Arriba M.L., Carvajal A., Pozo J., Rubio P. Lymphoproliferative responses and protection in conventional piglets inoculated orally with virulent or attenuated porcine epidemic diarrhoea virus. J. Virol. Methods. 105(1):2002;37-47.
26. Loa CC, Lin TL, Wu CC, et al. Humoral and cellular immune responses in turkey poults infected with turkey coronavirus 2001;80(10):1416-24.
27. Seo S.H., Collisson E.W. Cytotoxic T lymphocyte responses to infectious bronchitis virus infection. Adv. Exp. Med. Biol. 440:1998;455-460.
28. Ilkal M.A., Prasanna Y., Jacob P.G., Geevarghese G., Banerjee K. Experimental studies on the susceptibility of domestic pigs to West Nile virus followed by Japanese encephalitis virus infection and vice versa. Acta Virol. 38(3):1994;157-161.
29. Brim TA, VanCott JL, Lunney JK, Saif LJ. Cellular immune responses of pigs after primary inoculation with porcine respiratory coronavirus or transmissible gastroenteritis virus and challenge with transmissible gastroenteritis virus. Vet Immunol Immunopathol 48(1-2):35-54.
30. Pope M., Chung S.W., Mosmann T., Leibowitz J.L., Gorczynski R.M., Levy G.A. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection. J. Immunol. 156(9):1996;3342-3349.
31. Nicholls J.M., Poon L.L., Lee K.C. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 361(9371):2003;1773-1778.
32. Xue S., Jaszewski A., Perlman S. Identification of a CD4+ T cell epitope within the M protein of a neurotropic coronavirus. Virology. 208(1):1995;173-179.
33. van der Veen R.C. Immunogenicity of JHM virus proteins: characterization of a CD4+ T cell epitope on nucleocapsid protein which induces different T-helper cell subsets. Virology. 225(2):1996;339-346.
34. Boots AM, Kusters JG, van Noort JM, et al. Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus. Immunology 74(1):8-13.
35. Anton I.M., Sune C., Meloen R.H., Borras-Cuesta F., Enjuanes L. A transmissible gastroenteritis coronavirus nucleoprotein epitope elicits T helper cells that collaborate in the in vitro antibody synthesis to the three major structural viral proteins. Virology. 212(2):1995;746-751.
36. Pewe L., Xue S., Perlman S. Infection with cytotoxic T-lymphocyte escape mutants results in increased mortality and growth retardation in mice infected with a neurotropic coronavirus. J. Virol. 72(7):1998;5912-5918.
37. Marten N.W., Stohlman S.A., Smith-Begolka W.et al. Selection of CD8+ T cells with highly focused specificity during viral persistence in the central nervous system. J. Immunol. 162(7):1999;3905-3914.
38. Pewe L., Xue S., Perlman S. Cytotoxic T-cell-resistant variants arise at early times after infection in C57BL/6 but not in SCID mice infected with a neurotropic coronavirus. J. Virol. 71(10):1997;7640-7647.
39. de Haan C.A., Masters P.S., Shen X., Weiss S., Rottier P.J. The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology. 296(1):2002;177-189.
40. Welter M.W. Adaptation and serial passage of bovine coronavirus in an established diploid swine testicular cell line and subsequent development of a modified live vaccine. Adv. Exp. Med. Biol. 440:1998;707-711.
41. Farsang A., Ros C., Renstrom L.H., Baule C., Soos T., Belak S. Molecular epizootiology of infectious bronchitis virus in Sweden indicating the involvement of a vaccine strain. Avian Pathol. 31(3):2002;229-236.
42. Takamura K., Matsumoto Y., Shimizu Y. Field study of bovine coronavirus vaccine enriched with hemagglutinating antigen for winter dysentery in dairy cows. Can. J. Vet. Res. 66(4):2002;278-281.
43. Pratelli A., Tinelli A., Decaro N.et al. Efficacy of an inactivated canine coronavirus vaccine in pups. New Microbiol. 26(2):2003;151-155.
44. Ladman B.S., Pope C.R., Ziegler A.F.et al. Protection of chickens after live and inactivated virus vaccination against challenge with nephropathogenic infectious bronchitis virus. Avian Dis. 46(4):2002;938-944.
45. Wang X., Schnitzlein W.M., Tripathy D.N., Girshick T., Khan M.I. Construction and immunogenicity studies of recombinant fowl poxvirus containing the S1 gene of Massachusetts 41 strain of infectious bronchitis virus. Avian Dis. 46(4):2002;831-838.
46. Chen H., Schifferli D.M. Enhanced immune responses to viral epitopes by combining macrophage-inducible expression with multimeric display on a Salmonella vector. Vaccine. 19(20-22):2001;3009-3018.
47. Liu C., Kokuho T., Kubota T.et al. DNA mediated immunization with encoding the nucleoprotein gene of porcine transmissible gastroenteritis virus. Virus Res. 80(1-2):2001;75-82.
48. Koden M.J., Borst M.A., Horsinek M.C., Spaan W.J. Immunogenic peptide comprising a mouse hepatitis virus A59 B-cell epitope and an influenza virus T-cell epitope protects against lethal infection. J. Virol. 64(12):1990; 6270-6273.